Prime Intelligence Solutions Group Limited — Interim / Quarterly Report 2022

Nov 11, 2021

CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE "STOCK EXCHANGE")

GEM has been positioned as a market designed to accommodate small and mid-sized companies to which a higher investment risk may be attached than other companies listed on the Stock Exchange. Prospective investors should be aware of the potential risks of investing in such companies and should make the decision to invest only after due and careful consideration.

Given that the companies listed on GEM are generally small and mid-sized companies, there is a risk that securities traded on GEM may be more susceptible to high market volatility than securities traded on the Main Board of the Stock Exchange and no assurance is given that there will be a liquid market in the securities traded on GEM.

Hong Kong Exchanges and Clearing Limited and the Stock Exchange take no responsibility for the contents of this report, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this report.

This report, for which the directors (the "Directors") of Prime Intelligence Solutions Group Limited (the "Company") collectively and individually accept full responsibility, includes particulars given in compliance with the Rules Governing the Listing of Securities on GEM of the Stock Exchange for the purpose of giving information with regard to the Company. The Directors, having made all reasonable enquiries, confirm that to the best of their knowledge and belief the information contained in this report is accurate and complete in all material respects and not misleading or deceptive, and there are no other matters the omission of which would make any statement herein or this report misleading.

香港聯合交易所有限公司(「聯交所」)GEM的特色

GEM的定位,乃為中小型公司提供一個上市的市場,此等公司相比起其他在聯交所上市的公司帶有較高投資風險。有意投資者應瞭解投資於該 等公司的潛在風險,並應經過審慎周詳考慮後方作出投資決定。

由於GEM上市公司普遍為中小型公司,在GEM買賣的證券可能會較於聯交所主板買賣的證券承受較大的市場波動風險,同時亦無法保證在 GEM買賣的證券會有高流通量的市場。

香港交易及結算所有限公司及聯交所對本報告的內容概不負責,對其準確性或完整性亦不發表任何聲明,並明確表示概不就因本報告全部或任何 部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責任。

本報告載有根據聯交所GEM證券上市規則規定而提供有關匯安智能科技集團有限公司(「本公司」)的資料,本公司的董事(「董事」)願就本報告共 同及個別承擔全部責任。董事作出一切合理查詢後,確認就彼等所深知及確信,本報告所載資料在所有重大方面均屬準確完整,並無誤導或欺詐 成分;且本報告並無遺漏任何其他事宜,致使其所載任何陳述或本報告產生誤導。

Corporate Information 公司資料

REGISTERED OFFICE

Windward 3, Regatta Office Park P.O. Box 1350 Grand Cayman KY1-1108 Cayman Islands

HEADQUARTERS AND PRINCIPAL PLACE OF BUSINESS IN HONG KONG

Unit A, 6/F, TLP132 Nos. 132–134 Tai Lin Pai Road Kwai Chung, New Territories Hong Kong

EXECUTIVE DIRECTORS

Mr. Yuen Kwok Wai, Tony (Chairman and Chief Executive Officer) Ms. Yuen Mei Ling, Pauline Ms. Sun Ngai Chu, Danielle Mr. Mui Pak Kuen

NON-EXECUTIVE DIRECTOR

Mr. Yam Chiu Fan, Joseph

INDEPENDENT NON-EXECUTIVE DIRECTORS

Mr. Hui Man Ho, Ivan Mr. Chung Billy Mr. Poon Wai Hung Richard

AUTHORISED REPRESENTATIVES

Mr. Yuen Kwok Wai, Tony Mr. Chou Chiu Ho

COMPANY SECRETARY

Mr. Chou Chiu Ho (HKICPA, ACCA)

COMPLIANCE OFFICER

Ms. Yuen Mei Ling, Pauline

AUDIT COMMITTEE

Mr. Chung Billy (Chairman) Mr. Hui Man Ho, Ivan Mr. Poon Wai Hung Richard

註冊辦事處

Windward 3, Regatta Office Park P.O. Box 1350 Grand Cayman KY1-1108 Cayman Islands

香港總辦事處及主要營業地點

香港 新界葵涌 大連排道132–134號 TLP132六樓A室

執行董事

阮國偉先生(主席兼行政總裁) 阮美玲女士 孫毅珠女士 梅栢權先生

非執行董事 任超凡先生

獨立非執行董事

許文浩先生 鍾定縉先生 潘偉雄先生

授權代表 阮國偉先生 周昭何先生

公司秘書 周昭何先生(HKICPA, ACCA)

合規主任 阮美玲女士

潘偉雄先生

審核委員會 鍾定縉先生(主席) 許文浩先生

Corporate Information 公司資料

NOMINATION COMMITTEE

Mr. Hui Man Ho, Ivan (Chairman) Mr. Chung Billy Mr. Poon Wai Hung Richard

REMUNERATION COMMITTEE

Mr. Chung Billy (Chairman) Mr. Hui Man Ho, Ivan Mr. Poon Wai Hung Richard Ms. Yuen Mei Ling, Pauline

LEGAL ADVISER

As to Hong Kong law Hastings & Co.

AUDITOR

McMillan Woods (Hong Kong) CPA Limited 3/F., Winbase Centre 208 Queen's Road Central Hong Kong

PRINCIPAL SHARE REGISTRAR AND TRANSFER OFFICE IN THE CAYMAN ISLANDS

Ocorian Trust (Cayman) Ltd. Windward 3, Regatta Office Park P.O. Box 1350 Grand Cayman KY1-1108 Cayman Islands

HONG KONG BRANCH SHARE REGISTRAR AND TRANSFER OFFICE

Tricor Investor Services Limited Level 54, Hopewell Centre 183 Queen's Road East Hong Kong

PRINCIPAL BANKER

The Hongkong and Shanghai Banking Corporation Limited DBS Bank (Hong Kong) Limited

WEBSITE www.primeintelligence.com.hk

STOCK CODE

8379

提名委員會 許文浩先生(主席) 鍾定縉先生 潘偉雄先生

薪酬委員會 鍾定縉先生(主席)

許文浩先生 潘偉雄先生 阮美玲女士

法律顧問 有關香港法律 希仕廷律師行

核數師 長青(香港)會計師事務所有限公司 香港 皇后大道中208號 勝基中心3樓

開曼群島主要股份過戶登記處

Ocorian Trust (Cayman) Ltd. Windward 3, Regatta Office Park P.O. Box 1350 Grand Cayman KY1-1108 Cayman Islands

香港股份過戶登記分處

卓佳證券登記有限公司 香港 皇后大道東183號 合和中心54樓

主要往來銀行 香港上海滙豐銀行有限公司 星展銀行(香港)有限公司

網址 www.primeintelligence.com.hk

股份代號 8379

Unaudited Condensed Consolidated Statement of Profit or Loss and Other Comprehensive Income 未經審核簡明綜合損益及其他全面收益表

The Board (the "Board") of Directors (the "Director(s)") of Prime Intelligence Solutions Group Limited (the "Company") is pleased to present the unaudited condensed consolidated results of the Company and its subsidiaries (collectively referred to as the "Group") for the three and six months ended 30 September 2021 together with the unaudited and audited comparative figures for the corresponding period in 2020 as follows:

匯安智能科技集團有限公司(「本公司」)董事(「董事」)會(「董 事會」)欣然提呈以下本公司及其附屬公司(統稱「本集團」) 截至2021年9月30日止三個月及六個月的未經審核簡明綜 合業績,連同2020年同期未經審核及經審核比較數字:

			Three months ended 30 September 截至9月30日止三個月			Six months ended 30 September
					截至9月30日止六個月
			2021	2020	2021	2020
			2021年	2020年	2021年	2020年
			HK\$'000	HK\$'000	HK\$'000	HK\$'000
			千港元	千港元	千港元	千港元
		Notes	(unaudited)	(unaudited)	(unaudited)	(unaudited)
		附註			(未經審核) (未經審核) (未經審核) (未經審核)
Revenue	收益	4	12,422	12,432	25,854	22,853
Cost of sales and services rendered	銷售及提供服務成本		(7,379)	(7,586)	(15,168)	(12,851)
Gross profit	毛利		5,043	4,846	10,686	10,002
Other income	其他收入	5	35	769	38	1,341
Selling and distribution costs	銷售及分銷成本		(1,999)	(1,105)	(3,082)	(2,035)
Administrative and other	行政及其他經營開支
operating expenses			(6,125)	(5,807)	(12,425)	(10,687)
Reversal/(provision) of impairment	貿易應收款項減值虧損
losses on trade receivables	撥回╱(撥備)		(96)	110	(96)	110
Loss from operation	來自經營之虧損		(3,142)	(1,187)	(4,879)	(1,269)
Finance costs	財務成本		(27)	(52)	(60)	(93)
Loss before tax	除稅前虧損		(3,169)	(1,239)	(4,939)	(1,362)
Income tax expense	所得稅開支	6	(116)	(37)	(340)	(277)
Loss for the period	期內虧損	7	(3,285)	(1,276)	(5,279)	(1,639)
Other comprehensive income	期內其他全面收益,
for the period, net of tax:	扣除稅項:
Item that may be reclassified	可能重新分類至損益之
to profit or loss:	項目:
Exchange differences on translating	換算海外業務時之
foreign operations	匯兌差額		–	–	–	–
Total comprehensive income	本公司擁有人應佔期內
for the period attributable to	全面收益總額
the owners of the Company			(3,285)	(1,276)	(5,279)	(1,639)
Loss per share (HK cents)	每股虧損(港仙)
— Basic and diluted	— 基本及攤薄	9	(0.41)	(0.16)	(0.66)	(0.20)

Unaudited Condensed Consolidated Statement of Financial Position 未經審核簡明綜合財務狀況表

			30 September	31 March
			2021	2021
			2021年	2021年
			9月30日	3月31日
			HK\$'000	HK\$'000
			千港元	千港元
		Notes	(unaudited)	(audited)
		附註	(未經審核)	(經審核)
Non-current assets	非流動資產
Property, plant and equipment	物業、廠房及設備		1,182	1,095
Right-of-use assets	使用權資產		1,147	1,704
Intangible assets	無形資產		–	21
			2,329	2,820
Current assets	流動資產
Inventories	存貨		22,790	22,979
Trade receivables	貿易應收款項	10	12,150	9,547
Other receivables, prepayments and deposits	其他應收款項、預付款項及按金		5,882	2,493
Tax recoverable	可收回稅項		–	85
Bank and cash balances	銀行及現金結餘		48,891	59,172
			89,713	94,276
Current liabilities	流動負債
Trade payables	貿易應付款項	11	1,131	499
Other payables and accrued expenses	其他應付款項及應計費用		5,662	3,667
Lease liabilities	租賃負債		1,420	1,597
Contract liabilities	合約負債		5,515	7,681
Current tax liabilities	即期稅項負債		313	118
			14,041	13,562
Net current assets	流動資產淨值		75,672	80,714
Total assets less current liabilities	總資產減流動負債		78,001	83,534
Non-current liabilities	非流動負債
Lease liabilities	租賃負債		598	1,285
Contract liabilities	合約負債		478	45
			1,076	1,330
NET ASSETS	資產淨值		76,925	82,204
Capital and reserves	資本及儲備
Share capital	股本	12	8,000	8,000
Reserves	儲備		68,925	74,204
TOTAL EQUITY	總權益		76,925	82,204

Unaudited Condensed Consolidated Statement of Changes in Equity 未經審核簡明綜合權益變動表

		Share capital	Share premium	Merger reserve	Legal reserve	Foreign currency translation reserve 外幣換算	Retained profits	Total reserve	Total equity
		股本 HK\$'000	股份溢價 HK\$'000	合併儲備 HK\$'000	法定儲備 HK\$'000	儲備 HK\$'000	保留溢利 HK\$'000	總儲備 HK\$'000	總權益 HK\$'000
		千港元	千港元	千港元	千港元	千港元	千港元	千港元	千港元
Balance at 1 April 2020 (audited)	於2020年4月1日的餘額 (經審核)	8,000	51,682	17,079	12	(689)	12,683	80,767	88,767
Total comprehensive income for the period (unaudited)	期內全面收益總額 (未經審核)	–	–	–	–	–	(1,639)	(1,639)	(1,639)
Balance at 30 September 2020 (unaudited)	於2020年9月30日的 餘額(未經審核)	8,000	51,682	17,079	12	(689)	11,044	79,128	87,128
Balance at 1 April 2021 (audited) Total comprehensive income for the period (unaudited)	於2021年4月1日的 餘額(經審核) 期內全面收益總額 (未經審核)	8,000 –	51,682 –	17,079 –	12 –	(151) –	5,582 (5,279)	74,204 (5,279)	82,204 (5,279)
Balance at 30 September 2021 (unaudited)	於2021年9月30日的 餘額(未經審核)	8,000	51,682	17,079	12	(151)	303	68,925	76,925

Unaudited Condensed Consolidated Statements of Cash Flows

未經審核簡明綜合現金流量表

		Six months ended 30 September
		截至9月30日止六個月
		2021	2020
		2021年	2020年
		HK\$'000	HK\$'000
		千港元	千港元
		(unaudited)	(unaudited)
		(未經審核)	(未經審核)
Net cash (used in)/generated from operating activities 經營活動(所用)╱所得現金淨額		(8,007)	1,222
Purchases of property, plant and equipment	購買物業、廠房及設備	(279)	(117)
Other investing cash flows (net)	其他投資現金流量(淨額)	3	131
Net cash (used in)/from investing activities	投資活動(所用)╱所得現金淨額	(276)	14
Net cash used in financing activities	融資活動所用現金淨額	(1,998)	(1,138)
Net (decrease)/increase in cash and cash equivalent	現金及現金等價物(減少)╱增加淨額	(10,281)	98
Cash and cash equivalents at beginning of the period 期初現金及現金等價物		59,172	65,147
Cash and cash equivalents at end of the period	期末現金及現金等價物	48,891	65,245
Analysis of cash and cash equivalents consist of	現金及現金等價物的分析,包括
Bank and cash balances	銀行及現金結餘	48,891	65,245

1. GENERAL INFORMATION

The Company was incorporated in the Cayman Islands as an exempt company with limited liability under the Companies Law (as revised) of the Cayman Islands on 16 October 2015. The address of its registered office is Windward 3, Regatta Office Park, P.O. Box 1350, Grand Cayman, KY1-1108, Cayman Islands. Subsequent to the end of reporting period, the address of its principal place of business is located at Unit A, 6/F TLP132, Nos. 132–134 Tai Lin Pai Road, Kwai Chung, New Territories, Hong Kong. The Company's shares ("Shares") are listed on GEM of The Stock Exchange of Hong Kong Limited (the "Stock Exchange") since 14 February 2018 (the "Listing").

The Company is an investment holding company. The principal activities of its subsidiaries are sales of biometrics identification devices and other devices and accessories and provision of auxiliary and other services.

2. BASIS OF PRESENTATION AND PREPARATION OF FINANCIAL STATEMENTS

The unaudited condensed consolidated financial statements of the Group have been prepared in accordance with Hong Kong Accounting Standard 34 "Interim Financial Reporting" issued by the Hong Kong Institute of Certified Public Accountants (the "HKICPA") and the applicable disclosures required by the Rules Governing the Listing of Securities on GEM of the Stock Exchange (the "GEM Listing Rules").

The unaudited condensed consolidated financial statements of the Group are presented in Hong Kong dollars ("HK\$"), which is the functional currency of the Company.

The unaudited condensed consolidated results of the Group for the three and six months ended 30 September 2021 do not include all the information and disclosures required in the annual financial statements of the Group and should be read in conjunction with the consolidated financial statements of the Group for the year ended 31 March 2021 (the "2021 Consolidated Financial Statements"). Except as described in paragraph headed "Changes in accounting policies and disclosures" below, the accounting policies and methods of computation used in the preparation of the unaudited condensed consolidated results are consistent with those used in the 2021 Consolidated Financial Statements.

Changes in accounting policy and disclosures

The adoption of these new and amended HKFRSs had no significant effects on the results and financial position of the Group for the current and prior periods.

1. 一般資料

本公司於2015年10月16日根據開曼群島公司法(經 修訂)在開曼群島註冊成立為獲豁免有限公司。本公 司 註 冊 辦 事 處 地 址 為Windward 3, Regatta Office Park, P.O. Box 1350, Grand Cayman, KY1-1108, Cayman Islands。於報告期末後,其主要營業地點的 地址位於香港新界葵涌大連排道132–134號TLP132 六樓A室。本公司股份(「股份」)已自2018年2月14日 起在香港聯合交易所有限公司(「聯交所」)GEM上市 (「上市」)。

本公司為一間投資控股公司。本公司附屬公司的主要 業務為銷售生物特徵識別裝置、其他裝置及配件以及 提供配套及其他服務。

2. 財務報表的呈報及編製基準

本集團的未經審核簡明綜合財務報表乃根據香港會計 師公會(「香港會計師公會」)頒佈的香港會計準則第 34號「中期財務報告」,以及聯交所GEM證券上市規 則(「GEM上市規則」)規定的適用披露編製。

本集團的未經審核簡明綜合財務報表以港元(「港元」) 呈列,港元為本公司的功能貨幣。

本集團截至2021年9月30日止三個月及六個月的未 經審核簡明綜合業績並不包括本集團年度財務報表所 有所須資料及披露,並應與本集團截至2021年3月 31日止年度綜合財務報表(「2021綜合財務報表」)一 併閱讀。除下文「會計政策及披露的變更」一段所載 外,編製未經審核簡明綜合業績所用會計政策及計算 方法與2021綜合財務報表所用者貫徹一致。

會計政策及披露的變更

採納該等新訂及經修訂的香港財務報告準則對本集團 於本期間及過往期間的業績及財務狀況並無重大影 響。

3. SEGMENT INFORMATION

The Group has two reportable segments as follows:

• Sales of biometrics identification devices, security products and other accessories.
• Provision of auxiliary and other services including (i) maintenance, installation and solution services; and (ii) software licensing.

The Group's reportable segments are strategic business units that offer different products and services. They are managed separately because each business requires different technology and marketing strategies.

4. REVENUE

Revenue represents the invoiced values of goods sold and services rendered, after allowances for returns and discounts during the reporting periods.

3. 分部資料

本集團的兩個可呈報分部如下:

• 銷售生物特徵識別裝置、保安產品及其他配 件。
• 提供配套及其他服務,包括(i)維護、安裝及解 決方案服務;及(ii)軟件許可。

本集團的可呈報分部乃為提供不同產品及服務的策略 性業務單位。由於各業務要求不同技術及營銷策略, 故各可呈報分部乃個別管理。

4. 收益

收益指所售貨品及提供服務的發票值,於報告期內經 扣除退貨及折扣。

		Three months ended 30 September 截至9月30日止三個月	Six months ended 30 September 截至9月30日止六個月
	2021 2021年 HK\$'000 千港元 (unaudited) (未經審核)	2020 2020年 HK\$'000 千港元 (unaudited) (未經審核)	2021 2021年 HK\$'000 千港元 (unaudited) (未經審核)	2020 2020年 HK\$'000 千港元 (unaudited) (未經審核)
Sales of biometrics identification 銷售生物特徵識別裝置、 devices, security products 保安產品及其他配件 and other accessories Provision of auxiliary and 提供配套及其他服務 other services	8,656 3,766	8,994 3,438	17,752 8,102	15,763 7,090
	12,422	12,432	25,854	22,853

4. REVENUE (continued)

4. 收益(續)

			Three months ended 30 September 截至9月30日止三個月	Six months ended 30 September 截至9月30日止六個月
		2021	2020	2021	2020
		2021年	2020年	2021年	2020年
		HK\$'000	HK\$'000	HK\$'000	HK\$'000
Revenue from contracts with	香港財務報告準則第15號	千港元	千港元	千港元	千港元
customers within the scope	範圍內的客戶合約收益	(unaudited)	(unaudited)	(unaudited)	(unaudited)
of HKFRS 15		(未經審核)	(未經審核)	(未經審核)	(未經審核)
Recognised at a point in time	於某一時間點確認	9,697	9,747	19,832	17,125
Recognised over time	隨時間確認	2,725	2,685	6,022	5,728
		12,422	12,432	25,854	22,853

5. OTHER INCOME

5. 其他收入

			Three months ended 30 September 截至9月30日止三個月		Six months ended 30 September 截至9月30日止六個月
		2021	2020	2021	2020
		2021年	2020年	2021年	2020年
		HK\$'000	HK\$'000	HK\$'000	HK\$'000
		千港元	千港元	千港元	千港元
		(unaudited)	(unaudited)	(unaudited)	(unaudited)
		(未經審核)	(未經審核)	(未經審核)	(未經審核)
Interest income	利息收入		– 8	1	131
Government subsidies	政府補助		– 829	–	1,149
Others	其他		35 (68)	37	61
			35 769	38	1,341

6. INCOME TAX EXPENSES

6. 所得稅開支

	Three months ended 30 September 截至9月30日止三個月		Six months ended 30 September 截至9月30日止六個月
	2021	2020	2021	2020
	2021年	2020年	2021年	2020年
	HK\$'000	HK\$'000	HK\$'000	HK\$'000
	千港元	千港元	千港元	千港元
	(unaudited)	(unaudited)	(unaudited)	(unaudited)
	(未經審核)	(未經審核)	(未經審核)	(未經審核)
Provision for the period: 期內撥備: Hong Kong Special Administrative 中華人民共和國(「中國」) Region ("Hong Kong") of 香港特別行政區(「香港」) the People's Republic of 利得稅
China ("PRC") Profits Tax	116	37	340	277
	116	37	340	277

The Group is not subject to taxation in the Cayman Islands and the British Virgin Islands.

Under the two-tiered Profits Tax Regime, one of the Company's Hong Kong subsidiaries is subject to Hong Kong Profits Tax at the rate of 8.25% (three and six months ended 30 September 2020: 8.25%) for the first HK\$2 million of its estimated assessable profits and at 16.5% (three and six months ended 30 September 2020: 16.5%) on its estimated assessable profits above HK\$2 million. Other Hong Kong subsidiaries not qualifying for the two-tiered Profit Tax Regime are subject to Hong Kong Profits Tax at the rate of 16.5% for the three and six months ended 30 September 2021 (three and six months ended 30 September 2020: 16.5%).

The Group's subsidiary established and operated in the PRC is subject to PRC Enterprise Income Tax at the rate of 25% (three and six months ended 30 September 2020: 25%). No PRC Enterprise Income Tax has been provided for the three and six months ended 30 September 2021 (three and six months ended 30 September 2020: Nil) as the Group's PRC subsidiary did not generate any assessable profits during the reporting periods.

The Group's subsidiary established and operated in Macau Special Administrative Region ("Macau") of the PRC is subject to Macau Complementary Tax, under which taxable income of up to Macau Pataca ("MOP") 600,000 (three and six months ended 30 September 2020: MOP600,000) is exempted from taxation with taxable income beyond this amount to be taxed at the rate of 12% for the three and six months ended 30 September 2021 (three and six months ended 30 September 2020: 12%).

本集團毋須繳納開曼群島及英屬處女群島的稅項。

根據利得稅兩級制,本公司其中一間香港附屬公司須 就估計應課稅溢利的首2百萬港元按8.25%(截至 2020年9月30日止三個月及六個月:8.25%)稅率繳 納香港利得稅,並就超過2百萬港元的估計應課稅溢 利按16.5%(截至2020年9月30日止三個月及六個月: 16.5%)的稅率繳納香港利得稅。截至2021年9月30 日止三個月及六個月,其他不符合兩級利得稅制度的 香港附屬公司須按16.5%的稅率繳納香港利得稅(截 至2020年9月30日止三個月及六個月:16.5%)。

本集團在中國成立及經營的附屬公司須按稅率25% (截至2020年9月30日止三個月及六個月:25%)繳 納中國企業所得稅。截至2021年9月30日止三個月 及六個月內概無計提中國企業所得稅(截至2020年9 月30日止三個月及六個月:無),乃因為本集團的中 國附屬公司於報告期內並無產生任何應課稅溢利。

本集團在中國澳門特別行政區(「澳門」)成立及經營 的附屬公司須繳納澳門所得補充稅,截至2021年9 月30日止三個月及六個月,應課稅收入最高600,000 澳門幣(「澳門幣」)(截至2020年9月30日止三個月及 六個月:600,000澳門幣)豁免納稅,超出該金額的 應課稅收入按12%(截至2020年9月30日止三個月 及六個月:12%)的稅率納稅。

7. LOSS FOR THE PERIOD

7. 期內虧損

		Three months ended 30 September		Six months ended 30 September
		截至9月30日止三個月		截至9月30日止六個月
		2021	2020	2021	2020
		2021年	2020年	2021年	2020年
		HK\$'000	HK\$'000	HK\$'000	HK\$'000
		千港元	千港元	千港元	千港元
		(unaudited)	(unaudited)	(unaudited)	(unaudited)
		(未經審核)	(未經審核)	(未經審核)	(未經審核)
Depreciation	折舊
— Owned assets	— 自置資產	103	141	195	293
— Right of use assets	— 使用權資產	797	659	1,147	1,060
Staff costs (including Directors' emoluments)	員工成本(包括董事酬金)
— Salaries, bonus and allowances	— 薪金、花紅、津貼及
and other benefits in kind	其他實物利益	6,806	5,729	12,343	11,063
— Commission	— 佣金	153	142	317	254
— Retirement benefits scheme	— 退休福利計劃供款
contributions		350	220	665	411
		7,309	6,091	13,325	11,728
Cost of inventories sold	已售存貨成本	4,245	4,269	8,992	8,146
(Reversal)/provision of impairment	貿易應收款項減值
on trade receivable	(撥回)╱撥備	96	(110)	96	(110)
Foreign exchange losses, net	匯兌虧損淨額	62	99	91	23
Auditor's remuneration	核數師酬金	175	156	303	285

8. DIVIDEND

No dividend was declared or paid during the six months ended 30 September 2021 (six months ended 30 September 2020: Nil).

8. 股息

概無宣派或派付截至2021年9月30日止六個月的股 息(截至2020年9月30日止六個月:無)。

9. LOSS PER SHARE

(a) Basic loss per Share

1. 每股虧損

(a) 每股基本虧損 每股基本虧損乃基於以下數據計算:

The calculation of the basic loss per Share is based on the following:

		Three months ended 30 September 截至9月30日止三個月 2021		Six months ended 30 September 截至9月30日止六個月
		2021年 HK\$'000 千港元 (unaudited) (未經審核)	2020 2020年 HK\$'000 千港元 (unaudited) (未經審核)	2021 2021年 HK\$'000 千港元 (unaudited) (未經審核)	2020 2020年 HK\$'000 千港元 (unaudited) (未經審核)
Loss for the purpose of calculating basic loss per Share	用以計算每股基本虧損 的虧損	(3,285)	(1,276)	(5,279)	(1,639)
Number of Shares Weighted average number of ordinary Shares for the purpose of calculating	股份數目 用以計算每股基本虧損 的普通股加權平均數
basic loss per Share		800,000,000	800,000,000	800,000,000	800,000,000

(b) Diluted loss per Share

No diluted loss per Share was presented as the Company did not have any dilutive potential ordinary Shares outstanding during the three and six months ended 30 September 2021 and 2020.

(b) 每股攤薄虧損

並無可呈列的每股攤薄虧損,乃因本公司於截 至2021年及2020年9月30日止三個月及六個 月並無任何流通在外的潛在可攤薄普通股。

10. TRADE RECEIVABLES

10. 貿易應收款項

		As at	As at
		30 September	31 March
		2021	2021
		於2021年	於2021年
		9月30日	3月31日
		HK\$'000	HK\$'000
		千港元	千港元
		(unaudited)	(audited)
		(未經審核)	(經審核)
From third parties	來自第三方	12,772	10,102
Less: allowance for doubtful debts	減:呆賬撥備	(652)	(555)
		12,120	9,547
From related parties	來自關聯方	30	–
		12,150	9,547

Analysis of trade receivables due from related parties:

應收關聯方的貿易應收款項分析:

		As at	As at
		30 September	31 March
		2021	2021
		於2021年	於2021年
		9月30日	3月31日
		HK\$'000	HK\$'000
		千港元	千港元
		(unaudited)	(audited)
		(未經審核)	(經審核)
Long Yield Company Limited ("Long Yield')	隆逸有限公司(「隆逸」)	6	–
SoHo Business Center Limited ("SoHo')	SoHo Business Center Limited(「SoHo」)	24	–
		30	–

Mr. Yuen Kwok Wai, Tony ("Mr. Tony Yuen") and Ms. Yuen Mei Ling, Pauline ("Ms. Pauline Yuen") are able to exercise significant influence over Long Yield and SoHo (both are incorporated in Hong Kong).

The Group's trading terms with customers are mainly on credit. The credit period granted to the customers generally range from 30 to 90 days. The Group seeks to maintain strict control over its outstanding receivables. Overdue balances are reviewed regularly by the Directors.

阮國偉先生(「阮先生」)及阮美玲女士(「阮女士」)對 隆逸及SoHo(兩者均在香港註冊成立)具重大影響力。

本集團與客戶的貿易條款主要為賒賬。向客戶授出的 信貸期一般介乎30至90日。本集團設法對其未償還 應收款項進行嚴格控制。逾期結餘由董事定期審閱。

10. TRADE RECEIVABLES (continued)

10. 貿易應收款項(續)

An ageing analysis of the Group's trade receivables based on the invoice date is as follows:

本集團按發票日期計算的貿易應收款項的賬齡分析如 下:

		As at	As at
		30 September	31 March
		2021	2021
		於2021年	於2021年
		9月30日	3月31日
		HK\$'000	HK\$'000
		千港元	千港元
		(unaudited)	(audited)
		(未經審核)	(經審核)
0 to 90 days	0至90天	7,602	7,733
91 to 180 days	91至180天	3,208	771
181 to 365 days	181至365天	934	1,033
Over 365 days	365天以上	406	10
		12,150	9,547

11. TRADE PAYABLES

An ageing analysis of the Group's trade payables based on the invoice date is as follows:

11. 貿易應付款項

本集團按發票日期計算的貿易應付款項的賬齡分析如 下:

	As at	As at
	30 September	31 March
	2021	2021
	於2021年	於2021年
	9月30日	3月31日
	HK\$'000	HK\$'000
	千港元	千港元
	(unaudited)	(audited)
	(未經審核)	(經審核)
0 to 30 days 0至30天	662	152
31 to 60 days 31至60天	299	75
Over 60 days 60天以上	170	272
	1,131	499

12. SHARE CAPITAL

12. 股本

		Number of ordinary Shares 普通股數目
		Per share	HK\$'000
		每股	千港元
Authorised:	法定:
Ordinary Shares of HK\$0.01 each	每股面值0.01港元的普通股
As at 31 March 2021 (audited), 1 April 2021	於2021年3月31日(經審核)、2021年
and 30 September 2021 (unaudited)	4月1日及2021年9月30日(未經審核)	5,000,000,000	50,000
Issued and fully paid:	已發行及繳足:
As at 31 March 2021 (audited), 1 April 2021	於2021年3月31日(經審核)、2021年
and 30 September 2021 (unaudited)	4月1日及2021年9月30日(未經審核)	800,000,000	8,000
SHARE OPTION SCHEMES	13. 購股權計劃
The share option scheme of the Company (the "Share Option		本公司購股權計劃(「該購股權計劃」)乃根據當時本
Scheme") was adopted pursuant to a resolution passed by the then		公司股東(「股東」)於2018年1月18日通過的決議案

shareholders of the Company (the "Shareholders") on 18 January 2018 for the primary purpose to attract, retain and motivate talented participants, to strive for future developments and expansion of the Group. Eligible participants of the Share Option Scheme include any employees, executive Directors, non-executive Directors (including independent non-executive Directors), advisers, consultants of the Company or any of its subsidiaries.

The Share Option Scheme will remain valid and effective for a period of 10 years commencing on the date on which the Share Option Scheme was adopted, after which no further share options will be granted but the provisions of the Share Option Scheme shall in all other respects remain in full force and effect and share options which are granted during the life of the Share Option Scheme may continue to be exercisable in accordance with their terms of issue. The principal terms of the Share Option Scheme were summarised in the paragraph headed "Share Option Scheme" in Appendix IV to the prospectus (the "Prospectus") published by the Company in relation to the Listing. No share option has been granted, exercised, expired, cancelled or lapsed under the Share Option Scheme since its adoption and up to the date of this report.

14. CONTINGENT LIABILITIES

At 30 September 2021, the Group did not have any contingent liabilities.

採納,主要目的為吸引、保留及激勵有才能的參與者 為本集團的未來發展及擴展努力。該購股權計劃的合 資格參與者包括本公司或其任何附屬公司的任何僱 員、執行董事、非執行董事(包括獨立非執行董事)、 顧問及諮詢人。

該購股權計劃將於其獲採納之日起計10年期間維持 有效,其後不得再授出購股權,但該購股權計劃的條 文在所有其他方面將仍全面有效,而於該購股權計劃 有效期內已授出的購股權根據其發行條款仍可繼續行 使。該購股權計劃的主要條款概要載於本公司就上市 而刊發的招股章程(「招股章程」)附錄四「購股權計劃」 一段。自採納以來及直至本報告日期,概無購股權根 據該購股權計劃授出、行使、屆滿、註銷或失效。

14. 或然負債

於2021年9月30日,本集團並無任何或然負債。

15. RELATED PARTY TRANSACTIONS

Other than those balances of related parties disclosed elsewhere in the consolidated financial statements, the Group had the following material transactions with its related parties during the period.

(iii) Mr. Tony Yuen and Ms. Pauline Yuen are able to exercise control

over Brilliant.

(a) Transactions with related parties

15. 關聯方交易

除綜合財務報表其他章節披露的該等關聯方結餘外, 本集團於期內與其關聯方有下列重大交易。

(a) 與關聯方的交易

			Three months ended		Six months ended
			30 September		30 September
			截至9月30日止三個月		截至9月30日止六個月
			2021	2020	2021	2020
			2021年	2020年	2021年	2020年
			HK\$'000	HK\$'000	HK\$'000	HK\$'000
			千港元	千港元	千港元	千港元
		Note	(unaudited)	(unaudited)	(unaudited)	(unaudited)
		附註	(未經審核)	(未經審核)	(未經審核)	(未經審核)
Sales of goods to	向關聯公司銷售
related companies:	產品:
— Long Yield	— 隆逸	(i)	20	8	20	26
— SoHo	— SoHo	(i), (ii)	–	–	–	3
			20	8	20	29
Services rendered to	向關聯公司提供
related companies: — Long Yield	服務: — 隆逸	(i)	24	29	48	54
— SoHo	— SoHo	(i), (ii)	24	24	56	56
			48	53	104	110
Rental expenses paid to a related company:	已付一間關聯公司的 租金開支:
— Global Technology	— 犇雷集團有限公司
Corporation Limited	(「犇雷」)
("Global Technology")		(i), (ii)	225	225	450	450
— Brilliant Capital	— 卓基資本有限公司
Resources Limited	(「卓基」)
("Brilliant")		(i), (iii)	450	–	900	–
			675	225	1,350	450
Notes:				附註:
(i)	The pricing of the related party transactions are mutually agreed by			(i)	關聯方交易之定價由本集團及關聯公司共同
the Group and related companies.				協定。
(ii)	Mr. Tony Yuen and Ms. Pauline Yuen are able to exercise significant influence over SoHo and Global Technology.			(ii)	阮先生及阮女士對SoHo及犇雷具重大影響力。
				(iii)	阮先生及阮女士能夠控制卓基。

15. RELATED PARTY TRANSACTIONS (continued)

(b) Key management compensation

Key management mainly represents the Directors. Remuneration for key management personnel of the Group is as follows:

(b) 主要管理層薪酬 主要管理層主要指董事。本集團主要管理層的 薪酬如下:

	Three months ended 30 September 截至9月30日止三個月		Six months ended 30 September 截至9月30日止六個月
	2021 2020		2021	2020
	2021年	2020年	2021年	2020年
	HK\$'000	HK\$'000	HK\$'000	HK\$'000
	千港元	千港元	千港元	千港元
	(unaudited)	(unaudited)	(unaudited)	(unaudited)
	(未經審核)	(未經審核)	(未經審核)	(未經審核)
Salaries, bonus and allowances 薪金、花紅、津貼及
and other benefits in kind 其他實物利益	1,116	1,116	2,232	2,232
Retirement benefits scheme 退休福利計劃供款
contributions	18	18	36	36
	1,134	1,134	2,268	2,268

^15. 關聯方交易(續)

BUSINESS REVIEW

Overview

The Group is a provider of biometrics identification solutions in Hong Kong, Macau and the PRC. The Group derives revenue from the following business activities: (i) sales of products which include biometrics identification devices, and other devices and accessories; and (ii) provision of auxiliary and other services. The Group's biometrics identification devices have one or more of the following functions: (i) face identification; (ii) fingerprint identification; (iii) finger vein identification; (iv) hand geometry identification; and (v) iris identification. The revenue of the Group for the six months ended 30 September 2021 was approximately HK\$25.9 million, representing an increase by approximately 13.1% from approximately HK\$22.9 million for the six months ended 30 September 2020. The increase in revenue was mainly attributable to the net effect of (i) increase in sales of biometrics identification devices and other accessories by approximately HK\$2.0 million (or 12.6%) as compared with the corresponding period in 2020; and (ii) increase in revenue derived from provision of auxiliary and other services by approximately HK\$1.0 million (or 14.3%) as compared with the corresponding period in 2020.

Revenue represents the invoiced values of goods sold and services rendered, after allowances for returns and discounts during the reporting periods.

業務回顧 概覽

本集團為香港、澳門及中國的生物特徵識別解決方案供應 商。本集團透過以下業務活動產生收益:(i)產品銷售,包括 生物特徵識別裝置以及其他裝置及配件;及(ii)提供配套及 其他服務。本集團的生物特徵識別裝置有一個或以上的以下 功能:(i)人臉識別;(ii)指紋識別;(iii)指靜脈識別;(iv)掌形識 別;及(v)虹膜識別。截至2021年9月30日止六個月,本集 團的收益約為25.9百萬港元,較截至2020年9月30日止六 個月約22.9百萬港元增加約13.1%。收益增加主要由於以下 各項淨影響所致:(i)生物特徵識別裝置及其他配件銷售較 2020年同期增加約2.0百萬港元或12.6%;及(ii)來自提供配 套及其他服務的收益較2020年同期增加約1.0百萬港元或 14.3%。

收益指於報告期內經扣除退貨及折扣後所售貨品及提供服務 的發票值。

			For the six months ended 30 September 截至9月30日止六個月
		2021	2020
		2021年	2020年
		HK\$'000	HK\$'000
		千港元	千港元
Sales of biometrics identification devices,	銷售生物特徵識別裝置、保安產品
security products and other accessories	及其他配件	17,752	15,763
Provision of auxiliary and other services	提供配套及其他服務	8,102	7,090
		25,854	22,853

Outlook

The ordinary Shares of HK\$0.01 each have been successfully listed on GEM on 14 February 2018. The Board considers that such public listing status allows the Company to gain access to the capital market for corporate finance exercise, assists the Company in the future business development, enhances the Group's corporate profile and recognition and strengthens the Group's competitiveness.

展望

每股0.01港元的普通股已於2018年2月14日在GEM成功上 市。董事會認為,公眾上市地位可讓本公司利用資本市場進 行企業融資,有助本公司的未來業務發展、提升本集團的企 業形象及認受性以及加強本集團的競爭力。

Looking forward, the Group plans to generate further growth in existing business by strengthening its marketing capabilities and expanding its product portfolio through enhancing software development, with a view to further enlarging its market share in Hong Kong and Macau and becoming one of the active biometrics identification solutions providers in the PRC. As such, the Group plans to utilise the net proceeds from Listing on (i) launching affordable locally manufactured fingerprint identification devices as part of the expansion plan of the business in the Southern China; (ii) enhancing the quality of aftersales services and strengthening the operation support as part of the expansion plan of the business in the Southern China; (iii) improving its information technology system; and (iv) setting up a new and separate software development centre in the PRC to further enhance and develop the Group's software.

With the latest spread of novel coronavirus disease (COVID-19) in Hong Kong, the Group plans to diversify its business to maintain a healthy portfolio. Leveraging on the experience of the Directors, the Group considers setting up new business lines including artificial intelligence technology solutions, catering management and trade services.

On 27 October 2021, The Board proposes to change the dual foreign name in Chinese of the Company from "匯安智能科技集團有限公司" to "懶豬科技集 團 有 限 公 司" (the "Proposed Change of Company Name"). The English name of the Company will remain unchanged. The Board considers the name "懶豬科技" to be distinctive and humorous. It signifies the Group's ambition to provide smart technology solutions that help people to accomplish mundane tasks with ease. The Proposed Change of Company Name is conditional upon the passing of a special resolution approving the Proposed Change of Company Name by the Shareholders at an extraordinary general meeting and the approval being granted by the Registrar of Companies in the Cayman Islands for the Proposed Change of Company Name.

FINANCIAL REVIEW

Cost of sales and services rendered and gross profit

The majority of the Group's cost of sales and services rendered was costs of inventories sold. The Group's costs of inventories sold increased by approximately 11.1% to approximately HK\$9.0 million for the six months ended 30 September 2021 (six months ended 30 September 2020: approximately 8.1 million). The gross profit margin dropped from approximately 43.8% for the six months ended 30 September 2020 to approximately 41.3% for the six months ended 30 September 2021. The gross profit also raised from approximately HK\$10.0 million for the six months ended 30 September 2020 to approximately HK\$10.7 million for the six months ended 30 September 2021. The increase in gross profit was mainly due to (i) the increase in sales of biometrics identification devices and other accessories; and (ii) the increase in provision of auxiliary and other services.

展望將來,本集團計劃透過加強其營銷能力及軟件開發擴大 其產品組合,進一步發展其現有業務,旨在進一步擴大於香 港及澳門的市場佔有率及成為活躍的中國生物特徵識別解決 方案供應商之一。因此,本集團計劃動用上市所得款項淨 額,以(i)推出本地製造可負擔指紋識別裝置,作為拓展華南 地區業務計劃的一部分;(ii)提高售後服務的質量及加強營運 支援,作為拓展華南地區業務計劃的一部分;(iii)改進其資 訊科技系統;及(iv)於中國設立一個新的獨立軟件開發中心 以進一步提升及開發本集團的軟件。

由於香港近期新型冠狀病毒肺炎(新冠肺炎)疫情,本集團 計劃多元化其業務,維持穩健的組合。憑藉董事的經驗,本 集團考慮設立包括人工智能科技解決方案、餐飲管理及貿易 服務等新產業鏈。

於2021年10月27日,董事會建議將本公司之中文雙重外文 名稱由「匯安智能科技集團有限公司」更改為「懶豬科技集 團有限公司」(「建議更改公司名稱」)。本公司之英文名稱將 維持不變。董事會認為,「懶豬科技」之名稱別樹一幟,詼 諧逗趣。此舉表示本集團致力提供智能科技解決方案,幫助 人們輕鬆解決瑣事。建議更改公司名稱須待股東於股東特別 大會上通過批准建議更改公司名稱之特別決議案及開曼群島 公司註冊處處長批准建議更改公司名稱後,方可作實。

財務回顧 銷售及已提供服務成本及毛利

本集團大部分銷售及提供服務成本為已售存貨成本。截至 2021年9月30日止六個月,本集團的已售存貨成本增加約 11.1%至約9.0百萬港元(截至2020年9月30日止六個月: 約8.1百萬港元)。毛利率由截至2020年9月30日止六個月 約43.8%減少至截至2021年9月30日止六個月約41.3%。 毛利亦由截至2020年9月30日止六個月約10.0百萬港元增 加至截至2021年9月30日止六個月約10.7百萬港元。毛利 的增加主要由於(i)生物特徵識別裝置及其他配件銷售增加; 及(ii)提供配套及其他服務增加。

Expenses

Staff costs for the six months ended 30 September 2021 was approximately HK\$13.3 million (six months ended 30 September 2020: approximately HK\$11.7 million), representing an increase by approximately HK\$1.6 million as compared with that of last corresponding period, which was mainly due to the salary increment during the period.

Administrative expenses for the six months ended 30 September 2021 was approximately HK\$12.4 million (six months ended 30 September 2020: approximately HK\$10.7 million), representing an increase by approximately HK\$1.7 million as compared with the last corresponding period, which was mainly due to the increase in staff costs and legal and professional expenses.

Loss for the period

The Group incurred a net loss of approximately HK\$5.3 million for the six months ended 30 September 2021, as compared with a net loss of approximately HK\$1.6 million for the six months ended 30 September 2020. The increase in net loss was mainly due to (i) an increase in administrative expenses mainly from the increase in staff costs and legal and professional expenses; and (ii) the measures implemented by the governments of the PRC and Macau including locking down to control the rapid spread and reduce the scale of infection of COVID-19, which have affected the usual business activities of the areas and disrupted the daily operations of the Group.

The Board does not recommend the payment of dividends for the six months ended 30 September 2021.

Liquidity, financial resources and capital structure

Historically, the Group has funded the liquidity and capital requirements primarily through operating cash flows and bank borrowings. The Directors believe that with the new capital from the Listing, the Group is in a healthy financial position to expand its core business and to achieve its business objectives. As at 30 September 2021, the Group had no bank borrowings (as at 30 September 2020: Nil). The Group requires cash primarily for working capital needs. As at 30 September 2021, the Group had approximately HK\$48.9 million in bank and cash balances (as at 31 March 2021: approximately HK\$59.2 million).

Capital expenditure

The Group purchased property, plant and equipment amounting to approximately HK\$0.3 million for the six months ended 30 September 2021 (six months ended 30 September 2020: approximately HK\$0.1 million).

Capital commitments

The Group did not have any significant capital commitments as at 30 September 2021 (as at 31 March 2021: Nil).

開支

截至2021年9月30日止六個月,員工成本約為13.3百萬港 元(截至2020年9月30日止六個月:約11.7百萬港元),較 去年同期增加約1.6百萬港元,主要由於期內加薪所致。

截至2021年9月30日止六個月,行政開支約為12.4百萬港 元(截至2020年9月30日止六個月:約10.7百萬港元),較 去年同期增加約1.7百萬港元,主要由於員工成本以及法律 及專業開支增加所致。

期內虧損

截至2021年9月30日止六個月,本集團產生淨虧損約5.3 百萬港元,而截至2020年9月30日止六個月則產生淨虧損 約1.6百萬港元。淨虧損增加主要由於(i)行政開支增加,主 要由於員工成本以及法律及專業費用增加;及(ii)中國及澳 門政府推行封城等措施,以控制新冠肺炎(COVID-19)疫情 迅速蔓延並降低感染規模,該等措施對有關地區的日常業務 活動構成影響,並擾亂了本集團的日常運作。

董事會不建議就截至2021年9月30日止六個月派付股息。

流動資金、財務資源及資本結構

過往,本集團主要以經營現金流量及銀行借款撥付其流動資 金及資本需求。董事相信,由於上市獲得新資金,故本集團 的財政狀況穩健,足以擴充其核心業務及達至其業務目標。 於2021年9月30日,本集團並無銀行借款(於2020年9月 30日:無)。本集團的現金主要用於撥付營運資金需求。於 2021年9月30日,本集團的銀行及現金結餘約為48.9百萬 港元(於2021年3月31日:約59.2百萬港元)。

資本開支

截至2021年9月30日止六個月,本集團購買物業、廠房及 設備約0.3百萬港元(截至2020年9月30日止六個月:約0.1 百萬港元)。

資本承擔

於2021年9月30日,本集團並無任何重大資本承擔(於 2021年3月31日:無)。

Gearing ratio

As at 30 September 2021, the Group had no outstanding borrowings, accordingly there was no gearing ratio (as at 31 March 2021: HK\$Nil).

Note: Gearing ratio is calculated as the total debt divided by total equity.

Foreign currency risk

The Company does not have significant exposure on foreign currency risk.

The functional currency of the Group's entities are principally denominated in HK\$, Renminbi ("RMB") and MOP. The Group has certain exposure to foreign currency risk as some of its business transactions, assets and liabilities are denominated in currencies other than the functional currencies of respective Group entities such as United States dollars, RMB and EURO. As at the date of this report, the Group does not have a foreign currency hedging policy in respect of foreign currency transactions, assets and liabilities.

The Group did not engage in any derivatives agreement and did not commit to any financial instruments to hedge its foreign exchange exposure during the six months ended 30 September 2021.

Significant investments held, material acquisitions and disposals of subsidiaries, and future plans for material investments or capital assets

There were neither significant investments held as at 30 September 2021 nor material acquisitions and disposals of subsidiaries during the six months ended 30 September 2021. There is no plan for material investments or capital assets as at the date of this report.

Charges over assets of the Group

As at 30 September 2021, there was no charge over assets of the Group (as at 31 March 2021: HK\$Nil).

Interim dividend

The Board does not recommend the payment of an interim dividend for the six months ended 30 September 2021 (six months ended 30 September 2020: Nil).

資產負債比率

於2021年9月30日,本集團並無尚未償還借款,因此並無 資產負債比率(於2021年3月31日:零港元)。

附註: 資產負債比率乃按總負債除以總權益計算。

外幣風險 本公司並無面臨重大外幣風險。

本集團實體的功能貨幣主要以港元、人民幣(「人民幣」)及 澳門幣計值。由於本集團的部分業務交易、資產及負債乃以 本集團實體各自的功能貨幣以外的貨幣(如美元、人民幣及 歐元)計值,故本集團須面對若干外幣風險。截至本報告日 期,本集團並無就外幣交易、資產及負債制訂任何外幣對沖 政策。

截至2021年9月30日止六個月,本集團並無涉及任何衍生 工具協議,亦無使用任何金融工具對沖其匯兌風險。

所持重大投資、重大收購及出售附屬公司以及重大 投資或資本資產的未來計劃

於2021年9月30日並無持有重大投資,而截至2021年9月 30日止六個月亦無重大收購及出售附屬公司。於本報告日 期,並無重大投資或資本資產的計劃。

本集團的資產抵押

於2021年9月30日,本集團概無任何資產抵押(於2021年 3月31日:零港元)。

中期股息

董事會不建議就截至2021年9月30日止六個月派付中期股 息(截至2020年9月30日止六個月:無)。

Employees and remuneration policies

As at 30 September 2021, the Group had a total of 70 employees. The Group's staff costs for the six months ended 30 September 2021 amounted to approximately HK\$13.3 million (six months ended 30 September 2020: approximately HK\$11.7 million). The Group's remuneration policies are in line with the prevailing market practice and are determined on the basis of performance, qualification and experience of individual employee. The Group recognises the importance of a good relationship with its employees. The remuneration payable to its employees includes salaries and allowances. Other benefits and incentives include training and share option.

In Hong Kong, the Group's employees have participated in the mandatory provident fund prescribed by the Mandatory Provident Fund Schemes Ordinance (Chapter 485 of the Laws of Hong Kong). In the PRC, the Group's employees have participated in the basic pension insurance, basic medical insurance, unemployment insurance, occupational injury insurance, maternity insurance prescribed by the Social Insurance Law of the PRC (《中華人民共 和國社會保險法》), and housing fund prescribed by the Regulations on the Administration of Housing Fund (《住房公積金管理條例》). All PRC-based employees have the right to participate in the social insurance and housing provident fund schemes.

Share Option Schemes

The Share Option Scheme was adopted pursuant to a resolution passed by the then Shareholders on 18 January 2018 for the primary purpose to attract, retain and motivate talented participants, to strive for future developments and expansion of the Group. Eligible participants of the Share Option Scheme include any employees, executive Directors, non-executive Directors (including independent non-executive Directors), advisers, consultants of the Company or any of its subsidiaries.

The Share Option Scheme will remain valid and effective for a period of 10 years commencing on the date on which the Share Option Scheme was adopted, after which no further share options will be granted but the provisions of the Share Option Scheme shall in all other respects remain in full force and effect and share options which are granted during the life of the Share Option Scheme may continue to be exercisable in accordance with their terms of issue. The principal terms of the Share Option Scheme were summarised in the paragraph headed "Share Option Scheme" in Appendix IV to the Prospectus. No share options has been granted, exercised, expired, cancelled or lapsed under the Share Option Scheme since its adoption and up to the date of this report.

僱員及薪酬政策

於2021年9月30日,本集團共有70名僱員。截至2021年9 月30日止六個月,本集團的員工成本約為13.3百萬港元(截 至2020年9月30日止六個月:約11.7百萬港元)。本集團 的薪酬政策與現行市場慣例一致,並按個別僱員的表現、資 格及經驗釐定。本集團深明與其僱員保持良好關係的重要 性。應付僱員薪酬包括薪金及津貼。其他福利及獎勵包括培 訓及購股權。

在香港,本集團僱員已參與香港法例第485章《強制性公積 金計劃條例》規定的強制性公積金計劃。在中國,本集團僱 員已參與《中華人民共和國社會保險法》規定的基本退休保 險、基本醫療保險、失業保險、工傷保險及生育保險以及 《住房公積金管理條例》規定的住房公積金。所有駐中國僱員 均有權參與社會保險及住房公積金計劃。

購股權計劃

該購股權計劃乃根據當時股東於2018年1月18日通過的決 議案採納,主要目的為吸引、保留及激勵有才能的參與者為 本集團的未來發展及擴展作出貢獻。該購股權計劃的合資格 參與者包括本公司或其任何附屬公司的任何僱員、執行董 事、非執行董事(包括獨立非執行董事)、顧問及諮詢人。

該購股權計劃將於其獲採納之日起計10年內維持有效。其 後不得再授出購股權,惟該購股權計劃的條文在所有其他方 面將仍具十足效力及作用,而於該購股權計劃有效期內已授 出的購股權根據其發行條款仍可繼續行使。該購股權計劃的 主要條款概要載於招股章程附錄四「購股權計劃」一段。自 採納以來及直至本報告日期,概無購股權根據該購股權計劃 獲授出、行使、屆滿、註銷或失效。

Use of proceeds and actual progress of the Group's business objectives

The net proceeds from the Listing (after deducting the underwriting fees and other related expenses paid by the Company in connection with the share offer) which amounted to approximately HK\$44.5 million will be used for the intended purposes as set out in the section headed "Statement of Business Objectives and Strategies" of the Prospectus. Set out below is the actual usage of net proceeds up to the date of this report:

所得款項用途及本集團業務目標的實際進度

上市所得款項淨額(經扣除本公司就股份發售支付的包銷費 及其他相關開支後)約為44.5百萬港元,將用作招股章程「業 務目標及策略聲明」一節所載擬定用途。截至本報告日期為 止的所得款項淨額的實際用途載列如下:

		Net proceeds	Utilised	Unutilised
		所得款項淨額	已動用	尚未動用
		HK\$ million	HK\$ million	HK\$ million
		百萬港元	百萬港元	百萬港元
Expanding the business	拓展華南地區業務
in the Southern China
— launch of affordable locally manufactured	— 推出本地製造可負擔指紋識別
fingerprint identification devices	裝置	15.8	–	15.8
— enhancement of the quality of after-sales services and strengthening of	— 提高售後服務的質量及加強 營運支援
the operation support		5.1	(5.1)	–
Improving the information technology	改進資訊科技系統
system		5.0	(5.0)	–
Setting up a new and separate software development centre in the PRC	於中國設立一個新的獨立軟件開發 中心以進一步提升及開發
to further enhance and develop the Group's software	本集團的軟件	15.2	(15.2)	–
Working capital	營運資金	3.4	(3.4)	–
		44.5	(28.7)	15.8

As disclosed in the Prospectus, the Group's business objectives are to further its growth in existing business by strengthening marketing capabilities and expanding product portfolio through enhancing software development, in order to further enlarge its market share in Hong Kong and Macau and to become one of the active biometrics identification solutions providers in the PRC. The Directors intend to achieve the objectives by (i) launching affordable locally manufactured fingerprint identification devices as part of the expansion plan of the business in the Southern China; (ii) enhancing the quality of aftersales services and strengthening the operation support as part of the expansion plan of the business in the Southern China; (iii) improving the information technology system; and (iv) setting up a new and separate software development centre in the PRC to further enhance and develop the Group's software.

誠如招股章程所披露,本集團的業務目標為透過加強營銷能 力及加強軟件開發擴大產品組合,進一步發展其現有業務, 旨在進一步擴大於香港及澳門的市場佔有率及成為活躍的中 國生物特徵識別解決方案供應商之一。董事擬透過以下方式 達成目標:(i)推出本地製造可負擔指紋識別裝置,作為拓展 華南地區業務計劃的一部分;(ii)提高售後服務的質量及加強 營運支援,作為拓展華南地區業務計劃的一部分;(iii)改進 資訊科技系統;及(iv)於中國設立一個新的獨立軟件開發中 心以進一步提升及開發本集團的軟件。

The Group had planned to use approximately HK\$15.8 million of net proceeds to launch affordable locally manufactured fingerprint identification devices as part of the expansion plan of the business in the Southern China. The Group has not yet launched affordable locally manufactured fingerprint identification devices. The Group is reviewing the needs and timeframe for launch of affordable locally manufactured fingerprint identification devices so as to capture the above-mentioned low-end market in the PRC.

The Group had planned to use approximately HK\$5.1 million of net proceeds to enhance the quality of after-sales services and to strengthen the operation support as part of the expansion plan of the business in the Southern China. As at 30 September 2021, a total of approximately HK\$5.1 million was spent on enhancing the quality of after-sales services and strengthening the operation support as part of the expansion plan of the business in the Southern China.

The Group had planned to use approximately HK\$5.0 million of net proceeds to improve the information technology system. As at 30 September 2021, a total of approximately HK\$5.0 million was spent on improving the information technology system.

The Group had planned to use approximately HK\$15.2 million of net proceeds to set up a new and separate software development centre in the PRC to further enhance and develop the Group's software. As at 30 September 2021, a total of approximately HK\$15.2 million was spent on setting up a new and separate software development centre in the PRC to further enhance and develop the Group's software.

The Group had planned to use approximately HK\$3.4 million of net proceeds to working capital. As at 30 September 2021, a total of approximately HK\$3.4 million was spent on working capital.

CORPORATE GOVERNANCE PRACTICES

The Group has committed to upholding high standards of corporate governance. The Board considers that enhanced public accountability and corporate governance are beneficial to the healthy growth of the Group, improving customer and supplier confidence and safeguarding the interests of Shareholders.

The Company has adopted and complied with the Corporate Governance Code (the "CG Code") contained in Appendix 15 to the GEM Listing Rules as its own code and has complied with the CG Code from the date of Listing up to the date of this report, except for the following deviation.

本集團計劃動用約15.8百萬港元的所得款項淨額推出本地 製造可負擔指紋識別裝置作為拓展華南地區業務計劃的一部 分。本集團尚未推出本地製造可負擔指紋識別裝置。本集團 現正檢討是否需要推出本地製造可負擔指紋識別裝置,亦在 檢討其時間表,以把握上述中國低端市場機遇。

本集團計劃動用約5.1百萬港元的所得款項淨額提高售後服 務的質量及加強營運支援作為拓展華南地區業務計劃的一部 分。於2021年9月30日,合共約5.1百萬港元用於提高售後 服務的質量及加強營運支援作為拓展華南地區業務計劃的一 部分。

本集團計劃動用約5.0百萬港元的所得款項淨額改進資訊科 技系統。於2021年9月30日,合共約有5.0百萬港元用於改 進資訊科技系統。

本集團計劃動用約15.2百萬港元的所得款項淨額於中國設 立一個新的獨立軟件開發中心以進一步提升及開發本集團的 軟件。於2021年9月30日,合共約有15.2百萬港元用於中 國設立一個新的獨立軟件開發中心以進一步提升及開發本集 團的軟件。

本集團計劃動用約3.4百萬港元的所得款項淨額作為營運資 金。於2021年9月30日,合共約有3.4百萬港元用作營運資 金。

企業管治常規

本集團致力維持高水準企業管治。董事會認為增加公眾問責 性及企業管治有利於本集團穩健增長、提高顧客及供應商的 信心,以及保障股東的利益。

本公司已採納及遵守GEM上市規則附錄15所載之企業管治 守則(「企業管治守則」)作為其自身之守則,並自上市日期 起直至本報告日期遵守企業管治守則,惟下列偏離事項除 外。

Chairman and Chief Executive Officer

CG Code provision A.2.1 stipulates that the roles of chairman and chief executive officer should be separate and should not be performed by the same individual. Mr. Tony Yuen is the chairman and the chief executive officer of the Company. In view that Mr. Tony Yuen is one of the founders of the Group and has been operating and managing the Group since June 1999, the Board believes that it is in the best interest of the Group to have Mr. Tony Yuen taking up both roles for effective management and business development. Therefore the Board considers that such deviation from the CG Code provision A.2.1 is appropriate in the circumstance.

The Board has continued to monitor and review the corporate governance principles and practices to ensure compliance.

COMPLIANCE WITH THE REQUIRED STANDARD OF DEALINGS IN SECURITIES TRANSACTIONS BY DIRECTORS

The Company has adopted a code of conduct regarding securities transactions by Directors (the "Model Code") on terms no less exacting than the required standard of dealings (the "Required Standard of Dealings") as set out in Rules 5.48 to 5.67 of the GEM Listing Rules.

Upon specific enquiry made to all Directors, the Company was not aware of any non-compliance with the Model Code and the Required Standard of Dealings from the date of Listing up to the date of this report.

DIRECTORS' AND CHIEF EXECUTIVES' INTERESTS AND SHORT POSITIONS IN SHARES, UNDERLYING SHARES AND DEBENTURES OF THE COMPANY OR ANY ASSOCIATED CORPORATION

As at 30 September 2021, the interests and short positions of the Directors and chief executive of the Company in the shares, underlying shares and debentures of the Company or any of its associated corporations (within the meaning of Part XV of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) (the "SFO"), which were required to be notified to the Company and the Stock Exchange pursuant to Divisions 7 and 8 of Part XV of the SFO (including interests and short positions in which they were taken or deemed to have under such provisions of the SFO) or which were required pursuant to section 352 of the SFO to be entered in the register referred to therein, or which were required to be notified to the Company and the Stock Exchange pursuant to Rules 5.46 to 5.67 of the GEM Listing Rules were as follows:

主席及行政總裁

企業管治守則條文第A.2.1條規定,主席與行政總裁的角色 應予區分且不應由同一人士擔任。阮先生為本公司主席兼行 政總裁。鑒於阮先生為本集團創辦人之一且自1999年6月 起一直營運及管理本集團,董事會認為就有效管理及業務發 展而言,由阮先生同時出任兩個職位合乎本集團的最佳利 益。因此,董事會認為在有關情況下偏離企業管治守則條文 第A.2.1條實屬恰當。

董事會已持續監察及審閱企業管治原則及常規以確保合規。

遵守董事進行證券交易的規定準則

本公司就董事進行證券交易採納條款不遜於GEM上市規則 第5.48至5.67條所載交易必守準則(「交易必守準則」)之操 守守則(「標準守則」)。

經向全體董事進行具體查詢後,本公司並不知悉由上市日至 本報告日期有任何違反標準守則及交易必守準則的情況。

董事及最高行政人員於本公司或任何關聯法團 的股份、相關股份及債權證的權益及淡倉

於2021年9月30日,董事及本公司最高行政人員於本公司 或其任何相聯法團(定義見香港法律第571章證券及期貨條 例(「證券及期貨條例」)第XV部)的股份、相關股份及債權證 中,擁有根據證券及期貨條例第XV部第7及第8分部須知會 本公司及聯交所的權益及淡倉(包括彼等根據證券及期貨條 例有關條文被認為或視作擁有的權益及淡倉),或根據證券 及期貨條例第352條須記錄在該條文所述登記冊內的權益及 淡倉,或根據GEM上市規則第5.46至5.67條須知會本公司 及聯交所的權益及淡倉如下:

Long positions Ordinary Share	好倉 普通股
Name	Capacity and nature of interest		Number of Shares (note 1) 股份數目	Percentage of the Company's issued share capital 佔本公司已發行
姓名	身份及權益性質		(附註1)	股本之百分比
Mr. Yuen Kwok Wai, Tony ("Mr. Tony Yuen") (note 2)	Interest of controlled corporation		206,000,000 (L)	25.75%
阮國偉先生(「阮先生」()附註2)	受控制法團權益
Ms. Yuen Mei Ling, Pauline ("Ms. Pauline Yuen") (note 2)	Interest of controlled corporation		206,000,000 (L)	25.75%
阮美玲女士(「阮女士」()附註2)	受控制法團權益
Notes:		附註:
1. The letter "L" denotes a long position in the Shareholder's interest in the share capital of the Company.		1.	英文字母「L」表示股東於本公司股本的好倉。
2. Delighting View Global Limited ("Delighting View") directly holds 206,000,000 Shares. As Delighting View is beneficially owned as to 85% and 15% by Mr. Tony Yuen and Ms. Pauline Yuen respectively and Mr. Tony Yuen and Ms. Pauline Yuen are parties acting in concert, each of Mr. Tony Yuen and Ms. Pauline Yuen is deemed to be interested in all Shares held by Delighting View under the SFO.		2.	Delighting View所持有的所有股份中擁有權益。	Delighting View Global Limited(「Delighting View」)直接持有 206,000,000股股份。由於Delighting View分別由阮先生及阮 女士實益擁有85%及15%,且阮先生及阮女士為一致行動人 士,故根據證券及期貨條例,阮先生及阮女士各自被視為於
Save as disclosed above, as at the date of this report, none of the Directors and chief executive of the Company or their associates (as defined in the GEM Listing Rules) had any interests or short positions in any shares, underlying shares or debentures of the Company or any of its associated corporations (within the meaning of Part XV of the SFO) which were required to be notified				除上文所披露者外,於本報告日期,概無董事及本公司最高 行政人員或彼等之聯繫人(定義見GEM上市規則)於本公司 或其任何相聯法團(定義見證券及期貨條例第XV部)的任何 股份、相關股份或債權證中,擁有任何根據證券及期貨條例 第XV部第7及8分部須知會本公司及聯交所的權益或淡倉(包

to the Company and the Stock Exchange pursuant to Divisions 7 ad 8 of Part XV of the SFO (including interests or short positions which each of them has taken or deemed to be taken under the provisions of the SFO); or which were required, pursuant to section 352 of the SFO, to be entered into the register referred to therein; or which were required, pursuant to Rules 5.46 and 5.67 of the GEM Listing Rules to be notified to the Company and the Stock Exchange.

括根據證券及期貨條例有關條文彼等各自被當作或視為擁有 的權益或淡倉),或根據證券及期貨條例第352條須記錄於 該條例所指登記冊內的權益或淡倉,或根據GEM上市規則 第5.46至5.67條須知會本公司及聯交所的權益或淡倉。

SUBSTANTIAL SHAREHOLDERS' AND OTHER PERSONS' INTERESTS AND SHORT POSITIONS IN THE SHARES AND UNDERLYING SHARES OF THE COMPANY

As at 30 September 2021, so far as is known to the Directors, the following persons, not being Directors or chief executive of the Company had, or were deemed to have, interests or short position in the Shares or underlying Shares which would fall to be disclosed to the Company under the provisions of Divisions 2 and 3 of Part XV of the SFO; or which were recorded in the register required to be kept by the Company under section 336 of the SFO; or who is directly or indirectly, to be interested in 5% or more of the nominal value of any class of share capital carrying rights to vote in all circumstances at general meetings of the Company:

主要股東及其他人士於本公司股份及相關股份 的權益及淡倉

於2021年9月30日,據董事所知,下列人士(並非董事或本 公司最高行政人員)於股份或相關股份中擁有或被視為擁有 根據證券及期貨條例第XV部第2及3分部條文須向本公司披 露的權益或淡倉;或須記錄於本公司根據證券及期貨條例第 336條所存置登記冊的權益或淡倉;或直接或間接擁有附帶 權利於任何情況下均可在本公司的股東大會上投票的任何類 別股本面值5%或以上權益:

Long positions

Ordinary Shares

好倉 普通股

Name 姓名	Capacity and nature of interest 身份及權益性質	Number of shares (note 1) 股份數目 (附註1)	Percentage of the Company's issued share capital 佔本公司已發行 股本之百分比
Delighting View (note 2) Delighting View(附註2)	Beneficial owner 實益擁有人	206,000,000 (L)	25.75%
Kailong Asia Limited ("Kailong") (note 3) Kailong Asia Limited(「Kailong」()附註3)	Beneficial owner 實益擁有人	190,000,000 (L)	23.75%
Soleil Capital Limited ("Soleil") (note 3) Soleil Capital Limited(「Soleil」()附註3)	Interest of controlled corporation 受控制法團權益	190,000,000 (L)	23.75%
Teo Kian Huat ("Mr. Teo") (note 3) 張建發(「張先生」()附註3)	Interest of controlled corporation 受控制法團權益	190,000,000 (L)	23.75%
Notes:	附註:

• 1. The letter "L" denotes a long position in the Shareholder's interest in the share capital of the Company.
• 1. As Delighting View is beneficially owned as to 85% and 15% by Mr. Tony Yuen and Ms. Pauline Yuen respectively and Mr. Tony Yuen and Ms. Pauline Yuen are parties acting in concert, each of Mr. Tony Yuen and Ms. Pauline Yuen is deemed to be interested in all Shares held by Delighting View under the SFO.
• 1. As Kailong is beneficially owned entirely by Soleil, which is in turn ultimately owned entirely by Mr. Teo, each of Soleil and Mr. Teo is deemed to be interested in all Shares held by Kailong under the SFO.

Save as disclosed above, as at the date of this report, the Directors are not aware of any other person, other than the Directors and the chief executive of the Company who had, or was deemed to have, interests or short positions in the Shares or underlying Shares which would fall to be disclosed to the Company under the provisions of Divisions 2 and 3 of Part XV of the SFO or, which were recorded in the register required to be kept by the Company under section 336 of the SFO; or who is directly or indirectly, to be interested in 5% or more of the nominal value of any class of share capital carrying rights to vote in all circumstances at general meetings of the Company or options in respect of such share capital.

1. 英文字母「L」表示股東於本公司股本的好倉。

2. 1. 由於Delighting View分別由阮先生及阮女士實益擁有85%及 15%,且阮先生及阮女士為一致行動人士,故根據證券及期 貨條例,阮先生及阮女士各自被視為於Delighting View所持 有的所有股份中擁有權益。
3. 1. 由於Kailong由Soleil全資實益擁有,而Soleil最終由張先生全 資擁有,因此根據證券及期貨條例,Soleil及張先生各自均被 視為於Kailong持有的所有股份中擁有權益。

除上文所披露者外,於本報告日期,董事並不知悉任何其他 人士(董事及本公司最高行政人員除外)於股份或相關股份 中擁有或被視為擁有根據證券及期貨條例第XV部第2及3分 部條文須向本公司披露的權益或淡倉;或須記錄於本公司根 據證券及期貨條例第336條所存置登記冊的權益或淡倉;或 直接或間接擁有附帶權利於任何情況下均可在本公司股東大 會上投票的任何類別股本面值5%或以上權益或有關該股本 的購股權。

PURCHASES, SALES OR REDEMPTION OF LISTED SECURITIES OF THE COMPANY

Neither the Company nor any of its subsidiaries purchased, sold or redeemed any of the Company's listed securities during the six months ended 30 September 2021.

COMPETING INTERESTS

The Directors confirm that as at 30 September 2021, none of the Directors, the controlling shareholders of the Company and their respective associates (as defined in the GEM Listing Rules) had any interest in any business which competes or is likely to compete, directly or indirectly, with the business of the Group or any other conflicts of interest with the Group.

DISCLOSURES UNDER RULES 17.22 TO 17.24 OF THE GEM LISTING RULES

As at 30 September 2021, the Group had no circumstances which would give rise to a disclosure obligation under Rules 17.22 to 17.24 of the GEM Listing Rules.

AUDIT COMMITTEE

The Company has established an audit committee (the "Audit Committee") with written terms of reference in compliance with rules 5.28 and 5.29 of the GEM Listing Rules and code provisions C.3.3 and C.3.7 of the CG Code. The primary duties of the Audit Committee are to review and supervise the financial reporting process and internal control systems of the Group. The Audit Committee comprises three independent non-executive Directors, namely Mr. Chung Billy (chairman of the Audit Committee), Mr. Hui Man Ho, Ivan and Mr. Poon Wai Hung Richard.

The unaudited condensed consolidated financial statements of the Company for the three and six months ended 30 September 2021 have been reviewed by the Audit Committee. The Audit Committee is of the opinion that such financial information complies with the applicable accounting standards, the GEM Listing Rules and legal requirements, and that adequate disclosures have been made.

By order of the Board Prime Intelligence Solutions Group Limited 匯安智能科技集團有限公司 Mr. Yuen Kwok Wai, Tony Chairman

Hong Kong, 8 November 2021

As at the date of this report, the executive Directors are Mr. Yuen Kwok Wai, Tony, Ms. Yuen Mei Ling, Pauline, Ms. Sun Ngai Chu, Danielle and Mr. Mui Pak Kuen; the non-executive Director is Mr. Yam Chiu Fan, Joseph; and the independent non-executive Directors are Mr. Hui Man Ho, Ivan, Mr. Chung Billy and Mr. Poon Wai Hung Richard.

購買、出售或贖回本公司上市證券

截至2021年9月30日止六個月,本公司或其任何附屬公司 概無購買、出售或贖回本公司任何上市證券。

競爭權益

董事確認,於2021年9月30日,概無董事、本公司控股股 東及彼等各自的聯繫人(定義見GEM上市規則)與本集團業 務直接或間接構成競爭或可能構成競爭的任何業務中擁有任 何權益或與本集團有任何其他利益衝突。

根據GEM上市規則第17.22至17.24條作出披 露

於2021年9月30日,本集團並無出現須根據GEM上巿規則 第17.22至17.24條履行披露責任的情況。

審核委員會

本公司已遵循GEM上市規則第5.28及5.29條以及企業管治 守則條文第C.3.3及C.3.7條成立審核委員會(「審核委員 會」),並以書面列明其職權範疇。審核委員會的主要職責為 檢討及監察本集團的財務申報程序及內部監控系統。審核委 員會由三名獨立非執行董事組成,即鍾定縉先生(審核委員 會主席)、許文浩先生及潘偉雄先生。

本公司截至2021年9月30日止三個月及六個月的未經審核 簡明綜合財務報表已經審核委員會審閱。審核委員會認為, 有關財務資料符合適用會計準則、GEM上市規則及法定要 求,並已作出足夠披露。

承董事會命 Prime Intelligence Solutions Group Limited 匯安智能科技集團有限公司 主席 阮國偉先生

香港,2021年11月8日

於本報告日期,執行董事為阮國偉先生、阮美玲女士、孫毅 珠女士及梅栢權先生;非執行董事為任超凡先生;及獨立非 執行董事為許文浩先生、鍾定縉先生及潘偉雄先生。